PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75002-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)75002-6/fulltext
Title :
PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75002-6&doi=10.1016/S1098-3015(10)75002-6
First page :
Section Title :
Open access? :
No
Section Order :
926